Pharmaceutical composition and administrations thereof

Details for Australian Patent Application No. 2010282986 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Rowe, William; Hurter, Patricia; Young, Christopher R.; Dinehart, Kirk; Verwijs, Marinus Jacobus; Overhoff, Kirk; Grootenhuis, Peter D. J.; Botfield, Martyn; Grossi, Alfredo; Zlokarnik, Gregor; Van Goor, Fredrick F.

Agent Cullens

Pub. Number AU-A-2010282986

PCT Pub. Number WO2011/019413

Priority 12/583,066 13.08.09 US; PCT/ US2009/004629 13.08.09 US

Filing date 18 February 2010

Wipo publication date 17 February 2011

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 31/47 (2006.01) - Quinolines

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

16 February 2012 PCT application entered the National Phase

  PCT publication WO2011/019413 Priority application(s): WO2011/019413

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010282990-Pyrido [4, 3-b] indoles and methods of use

2010282983-Ophthalmic drug delivery system containing phospholipid and cholesterol